RESUMO
We and others have shown that HIV-1 highly-exposed seronegative (HESN) female commercial sex workers (CSWs) maintain low genital inflammatory conditions to prevent HIV infection. HIV-1 interacts with toll-like receptors (TLR)-7/8 to induce interferon (IFN)-α, an important antiviral and immunomodulatory cytokine, which act together with interleukin (IL)-10, human leukocyte antigen (HLA)-G and immunoglobulin-like transcript (ILT)-4 to initiate a "tolerogenic/regulatory" anti-inflammatory loop. In view of further unravelling elements associated with natural immunity to HIV-1, we have characterised TLR-7, IFN-α, IL-10, HLA-G and ILT-4 expression profiles in the genital tract of female CSWs and HIV-1-uninfected non-CSWs from Benin. Endocervical myeloid HLA-DR+ cells from HESN CSWs expressed higher levels of IFN-α, TLR-7, IL-10 and HLA-G than those from both HIV-1-infected CSWs and HIV-1-uninfected non-CSWs. Further characterization of the endocervical myeloid HLA-DR+ cells in HESN CSWs revealed a population of "tolerogenic" CD103+ CD14+ CD11c+ myeloid cells expressing high levels of IFN-α and IL-10. Concomitantly, HESN CSWs had higher frequencies of endocervical regulatory CD4+ T-cells when compared to those from the two other groups of women. These novel findings provide strong evidence to support the implication of tolerogenic myeloid cells expressing high levels of antiviral molecules in shaping the genital mucosal immune response to prevent HIV infection.
Assuntos
Soronegatividade para HIV/imunologia , HIV-1/imunologia , Mucosa/imunologia , Células Mieloides/imunologia , Trabalho Sexual/estatística & dados numéricos , Linfócitos T Reguladores/imunologia , Adulto , Benin , Citocinas/imunologia , Citocinas/metabolismo , Feminino , Genitália Feminina/imunologia , Genitália Feminina/metabolismo , Infecções por HIV/diagnóstico , Infecções por HIV/imunologia , Infecções por HIV/virologia , HIV-1/fisiologia , Humanos , Imunidade nas Mucosas/imunologia , Pessoa de Meia-Idade , Mucosa/metabolismo , Células Mieloides/metabolismo , Linfócitos T Reguladores/metabolismoRESUMO
Initial exposure to human immunodeficiency virus type 1 (HIV-1) during heterosexual transmission occurs in the genital tract. Although much of the literature on the immune response to HIV-1 infection is based on studies performed at the systemic level, our understanding of tissue-specific immunity is lacking. Levels of both genital mucosal and blood interleukin (IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma production were compared between 57 HIV-1-uninfected and 52 HIV-1-infected female commercial sex workers (CSWs) as well as 73 HIV-1-uninfected non-CSW control women at low risk for exposure. HIV-1-infected CSWs had significantly higher genital mucosal levels of TNF-alpha and IFN-gamma compared with those in both the HIV-uninfected CSW and non-CSW groups. In contrast, the serum levels of all the cytokines tested were lower in HIV-1-infected CSWs compared with those in the other groups. The increased production of genital mucosal pro-inflammatory cytokines in HIV-1-infected CSWs possibly reflects susceptibility to HIV-1 infection and disease progression/perpetuation at the initial site of exposure.
Assuntos
Citocinas/metabolismo , Genitália Feminina/metabolismo , Infecções por HIV/metabolismo , HIV-1 , Mucosa/imunologia , Trabalho Sexual , Adulto , Benin , Citocinas/sangue , Feminino , Genitália Feminina/imunologia , Infecções por HIV/imunologia , Humanos , Ducha Vaginal/métodosRESUMO
The human immunodeficiency virus type 1 (HIV-1) Nef protein is an important determinant of AIDS pathogenesis. We have previously reported that HIV-1 Nef is responsible for the induction of a severe AIDS-like disease in CD4C/HIV transgenic (Tg) mice. To understand the molecular mechanisms of this Nef-induced disease, we generated Tg mice expressing a mutated Nef protein in which the SH3 ligand-binding domain (P(72)XXP(75)XXP(78)) was mutated to A(72)XXA(75)XXQ(78). This mutation completely abolished the pathogenic potential of Nef, although a partial downregulation of the CD4 cell surface expression was still observed in these Tg mice. We also studied whether Hck, one of the effectors previously found to bind to this PXXP motif of Nef, was involved in disease development. Breeding of Tg mice expressing wild-type Nef on an hck(-/-) (knockout) background did not abolish any of the pathological phenotypes. However, the latency of disease development was prolonged. These data indicate that an intact PXXP domain is essential for inducing an AIDS-like disease in CD4C/HIV Tg mice and suggest that interaction of a cellular effector(s) with this domain is required for the induction of this multiorgan disease. Our findings indicate that Hck is an important, but not an essential, effector of Nef and suggest that another factor(s), yet to be identified, may be more critical for disease development.
Assuntos
Genes nef , Infecções por HIV/virologia , HIV-1/genética , Proteínas Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/genética , Animais , Antígenos CD4/genética , Infecções por HIV/genética , HIV-1/patogenicidade , Humanos , Camundongos , Camundongos Transgênicos , Mutação , Proteínas Proto-Oncogênicas c-hck , Virulência/genética , Replicação Viral/genética , Domínios de Homologia de srcRESUMO
To identify the regulatory elements controlling expression of the human CD4 (hCD4) gene in different cell types of the immune system, deletion and chimeric (human/murine) reporter genes were constructed and tested in transgenic (Tg) mice. Regulatory elements required for the proper hCD4 expression in the immature double-positive thymic T cells were identified in the enhancer and in the 3' end of intron 1. Expression of hCD4 in macrophages is controlled by at least 2 sets of regulatory elements: one present in front of exon 1 and the second at the 5' end of intron 1. The hCD4 elements required for expression on both myeloid and lymphoid CD8alpha(+) dendritic cells (DCs) from lymph node and thymus were found to be different from those required for macrophage expression. The results indicate that expression of hCD4 in T cells, macrophages, and DCs is controlled by distinct regulatory elements.
Assuntos
Antígenos CD4/genética , Células Dendríticas/metabolismo , Genes Reguladores/genética , Macrófagos/metabolismo , Linfócitos T/metabolismo , Animais , Northern Blotting , Antígenos CD4/metabolismo , DNA/metabolismo , Citometria de Fluxo , Regulação da Expressão Gênica/genética , Humanos , Camundongos , Camundongos Transgênicos , Distribuição TecidualRESUMO
The mechanisms responsible for degeneration of germinal centers (GC) and follicular dendritic cell (FDC) networks during progression to AIDS remain elusive. Here, we show that CD4(+) T cells from CD4C/HIV-1 Tg mice, which develop a severe AIDS-like disease, express low levels of CD40 ligand. Accordingly, GC formation, FDC networks, and immunoglobulin isotype switching are impaired in these animals. However, Tg B cells respond to in vitro CD40 stimulation. Total serum IgG levels are reduced in Tg mice, whereas total IgM levels are increased with a significant amount showing DNA specificity. IFN-gamma- and IL-6-deficient CD4C/HIV Tg mice also develop the AIDS-like disease and produce auto-Ab. Thus, CD4C/HIV Tg mice have immune dysfunction accompanied by autoimmune responses.
Assuntos
Síndrome da Imunodeficiência Adquirida/imunologia , Autoanticorpos/sangue , Antígenos CD4/imunologia , Centro Germinativo/imunologia , HIV-1/imunologia , Síndrome da Imunodeficiência Adquirida/etiologia , Animais , Linfócitos B , Antígenos CD4/genética , Produtos do Gene nef/imunologia , Genes nef , HIV-1/genética , Células-Tronco Hematopoéticas , Switching de Imunoglobulina , Imunoglobulina M/sangue , Interferon gama/metabolismo , Interleucina-6/metabolismo , Ativação Linfocitária , Camundongos , Camundongos Transgênicos , Mutação , Produtos do Gene nef do Vírus da Imunodeficiência HumanaRESUMO
BACKGROUND: Tyrosinemia type I, the most severe disease of the tyrosine catabolic pathway is caused by a deficiency in fumarylacetoacetate hydrolase (FAH). A patient showing few of the symptoms associated with the disease, was found to be a compound heterozygote for a splice mutation, IVS6-1g->t, and a putative missense mutation, Q279R. Analysis of FAH expression in liver sections obtained after resection for hepatocellular carcinoma revealed a mosaic pattern of expression. No FAH was found in tumor regions while a healthy region contained enzyme-expressing nodules. RESULTS: Analysis of DNA from a FAH expressing region showed that the expression of the protein was due to correction of the Q279R mutation. RT-PCR was used to assess if Q279R RNA was produced in the liver cells and in fibroblasts from the patient. Normal mRNA was found in the liver region where the mutation had reverted while splicing intermediates were found in non-expressing regions suggesting that the Q279R mutation acted as a splicing mutation in vivo. Sequence of transcripts showed skipping of exon 8 alone or together with exon 9. Using minigenes in transfection assays, the Q279R mutation was shown to induce skipping of exon 9 when placed in a constitutive splicing environment. CONCLUSION: These data suggest that the putative missense mutation Q279R in the FAH gene acts as a splicing mutation in vivo. Moreover FAH expression can be partially restored in certain liver cells as a result of a reversion of the Q279R mutation and expansion of the corrected cells.
Assuntos
Predisposição Genética para Doença , Hidrolases/genética , Mutação de Sentido Incorreto , Splicing de RNA , Tirosinemias/genética , Análise Mutacional de DNA , Feminino , Fibroblastos/metabolismo , Humanos , Hidrolases/metabolismo , Lactente , Fígado/metabolismo , Mutação , RNA Mensageiro/metabolismo , Tirosinemias/metabolismoRESUMO
Autoantibodies against certain stress or heat shock proteins (Hsps) may play a role in the pathogenesis and/ or prognosis of some diseases. Using immunoblotting with human recombinant Hsps and univariate and multivariate logistic regression models, we have investigated the presence of antibodies against Hsp70, the inducible member of the 70-kDa family of heat shock proteins, and analyzed its possible association with hypertension and working conditions. Plasma and serum were collected from 764 steel mill workers from 6 work sites exposed to (1) severe noise; (2) severe noise and dust; (3) noise, dust, and heat; (4) noise and heat; (5) severe noise and heat; and (6) office conditions (control). Workers with prolonged exposure to stresses such as noise, dust, and high temperature and a combination of these in the workplace had a high incidence (26.6% to 40.2%) of antibodies to Hsp70 compared to the lowest incidence (18.6%) of antibodies to Hsp70 in the control group of office workers. Moreover, there was a statistical association of antibodies against Hsp70 with hypertension. The statistical correlation between the presence of antibodies to Hsp70 and hypertension is higher in the group of workers with blood pressure of 160/95 mmHg than in the 140/90-mmHg group after excluding possible effects of the workplace stresses. These results suggest that harsh workplace conditions can increase the production of antibodies against Hsp70 and that the presence of antibodies to this stress protein may be associated with hypertension. The precise mechanism for the elevation of antibodies against Hsps by environmental and workplace stresses and their relation to hypertension remains to be established.
Assuntos
Autoanticorpos/sangue , Proteínas de Choque Térmico HSP70/imunologia , Hipertensão/imunologia , Exposição Ocupacional/efeitos adversos , Pressão Sanguínea , Monóxido de Carbono/efeitos adversos , China , Poeira/efeitos adversos , Nível de Saúde , Resposta ao Choque Térmico , Temperatura Alta/efeitos adversos , Humanos , Hipertensão/etiologia , Hipertensão/fisiopatologia , Metalurgia , Ruído/efeitos adversos , Fatores de RiscoRESUMO
Responsiveness to IL-13 involves at least two chains, IL-4Ralpha and IL-13Ralpha1. Although mouse B cells express IL-4Ralpha, little is known about their expression of IL-13Ralpha chains. To investigate this topic further, we have generated a monoclonal antibody (C41) specific for murine IL-13Ralpha1. Using C41, IL-13Ralpha1 expression was detected on germinal center (GC) B cells by flow cytometry and immunohistochemistry. In addition, IL-13Ralpha1 was observed on follicular dendritic cells, but not interdigitating dendritic cells in the T cell areas. Furthermore, resting B cells also expressed IL-13Ralpha1, and in the presence of IL-13 produced increased amounts of IgM in response to in vitro CD40 stimulation. However, C41 was unable to neutralize this bioactivity. The distribution of IL-13Ralpha1 on murine B cells and during GC reactions suggests a role for IL-13 during B cell differentiation.
Assuntos
Anticorpos Monoclonais/imunologia , Linfócitos B/imunologia , Células Dendríticas Foliculares/imunologia , Receptores de Interleucina/imunologia , Animais , Anticorpos Monoclonais/isolamento & purificação , Especificidade de Anticorpos , Subunidade alfa1 de Receptor de Interleucina-13 , Camundongos , Receptores de Interleucina/biossíntese , Receptores de Interleucina-13RESUMO
Tyrosinaemia I (fumarylacetoacetate hydrolase deficiency) is an autosomal recessive inborn error of tyrosine metabolism that produces liver failure in infancy or a more chronic course of liver disease with cirrhosis, often complicated by hepatocellular carcinoma, in childhood or early adolescence. We studied a 37-year-old woman with tyrosinaemia I whose severe liver disease in infancy and rickets during childhood resolved with dietary therapy. From 14 years of age she resumed an unrestricted diet with the continued presence of the biochemical features of tyrosinaemia, yet maintained normal liver function. In adult years she accumulated only small amounts of succinylacetone. Despite this evolution to a mild biochemical and clinical phenotype, she eventually developed hepatocellular carcinoma. Her fumarylacetoacetate hydrolase genotype consists of a splice mutation, IVS6-1g>t, and a novel missense mutation, Q279R. Studies of resected liver demonstrated the absence of hydrolytic activity and of immunological expression of fumarylacetoacetate hydrolase in liver tumour. In nontumoral areas, however, 53% of normal hydrolytic activity and immunologically present fumarylacetoacetate hydrolase was found. This case demonstrates the high risk of liver cancer in tyrosinaemia I even in a seemingly favourable biological environment.
Assuntos
Carcinoma Hepatocelular/enzimologia , Hidrolases/genética , Neoplasias Hepáticas/enzimologia , Fígado/enzimologia , Splicing de RNA , Tirosinemias/enzimologia , Adulto , Carcinoma Hepatocelular/complicações , Carcinoma Hepatocelular/genética , Doença Crônica , Feminino , Humanos , Hidrolases/deficiência , Hidrolases/metabolismo , Fígado/patologia , Neoplasias Hepáticas/complicações , Neoplasias Hepáticas/genética , Masculino , Linhagem , Sobreviventes , Tirosinemias/complicações , Tirosinemias/genéticaRESUMO
B cells convert what are normally conditions for Th1 differentiation into an environment suitable for Th2 development. This capacity is dependent on CD40 as B cells from CD40-/- mice do not elicit Th2 differentiation. To elucidate the basis of this effect, we surveyed cytokine RNA made by naive B cells after activation with anti-Ig and anti-CD40. Resting B cells make TGF-beta message only, however, 4 days after activation, RNA encoding IL-6, IL-10, and TNF-alpha was found. The expression of these messages was accelerated by 2 days in the presence of IL-12. The relevance of these observations to T cell differentiation was investigated: addition of OVA peptide to splenic cells from DO.11.10 transgenic mice causes most T cells to make IFN-gamma. Coactivation of B cells in these cultures reduces the number of IFN-gamma-producing T cells and increases the number synthesizing IL-4. Abs to IL-6 and IL-10 block the IL-4 enhancement. Dissection of the component APC demonstrated that interaction of B cells with IL-12-producing dendritic cells is crucial for B cell-mediated IL-4 enhancement: Thus, B cells preactivated in the presence of dendritic cells from IL-12-/- mice show little IL-4-inducing activity when used to activate T cells. This immune regulation is initiated by IL-12 and therefore represents a feedback loop to temper its own dominant effect (IFN-gamma induction).
Assuntos
Linfócitos B/imunologia , Células Dendríticas/fisiologia , Interleucina-12/fisiologia , Células Th1/citologia , Células Th2/citologia , Adjuvantes Imunológicos/fisiologia , Animais , Linfócitos B/metabolismo , Antígenos CD40/genética , Antígenos CD40/fisiologia , Comunicação Celular/imunologia , Diferenciação Celular/imunologia , Sistema Livre de Células/imunologia , Células Cultivadas , Meios de Cultivo Condicionados/farmacologia , Citocinas/biossíntese , Citocinas/genética , Células Dendríticas/imunologia , Regulação para Baixo/imunologia , Retroalimentação/fisiologia , Interleucina-10/fisiologia , Interleucina-12/antagonistas & inibidores , Interleucina-12/biossíntese , Interleucina-12/genética , Interleucina-4/biossíntese , Interleucina-4/metabolismo , Interleucina-6/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , RNA Mensageiro/biossíntese , Subpopulações de Linfócitos T/metabolismo , Células Th1/imunologia , Células Th2/imunologiaRESUMO
A functional IL-13R involves at least two cell surface proteins, the IL-13R alpha 1 and IL-4R alpha. Using a soluble form of the murine IL-13R alpha 1 (sIL-13R), we reveal several novel features of this system. The sIL-13R promotes proliferation and augmentation of Ag-specific IgM, IgG2a, and IgG2b production by murine germinal center (GC) B cells in vitro. These effects were enhanced by CD40 signaling and were not inhibited by an anti-IL4R alpha mAb, a result suggesting other ligands. In GC cell cultures, sIL-13R also promoted IL-6 production, and interestingly, sIL-13R-induced IgG2a and IgG2b augmentation was absent in GC cells isolated from IL-6-deficient mice. Furthermore, the effects of the sIL-13R molecule were inhibited in the presence of an anti-IL-13 mAb, and preincubation of GC cells with IL-13 enhanced the sIL-13R-mediated effects. When sIL-13R was injected into mice, it served as an adjuvant-promoting production to varying degrees of IgM and IgG isotypes. We thus propose that IL-13R alpha 1 is a molecule involved in B cell differentiation, using a mechanism that may involve regulation of IL-6-responsive elements. Taken together, our data reveal previously unknown activities as well as suggest that the ligand for the sIL-13R might be a component of the IL-13R complex or a counterstructure yet to be defined.
Assuntos
Linfócitos B/imunologia , Centro Germinativo/imunologia , Imunoglobulina G/biossíntese , Interleucina-13/fisiologia , Receptores de Interleucina/fisiologia , Animais , Linfócitos B/metabolismo , Sequência de Bases , Células Cultivadas , Feminino , Centro Germinativo/citologia , Tolerância Imunológica , Isotipos de Imunoglobulinas/biossíntese , Injeções Subcutâneas , Subunidade alfa1 de Receptor de Interleucina-13 , Interleucina-6/genética , Interleucina-6/metabolismo , Interleucina-6/fisiologia , Ativação Linfocitária/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Dados de Sequência Molecular , Receptores de Interleucina/administração & dosagem , Receptores de Interleucina/metabolismo , Receptores de Interleucina-13 , SolubilidadeRESUMO
Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetate hydrolase and mainly affects the liver. This disease is characterized by the presence of a high level of succinylacetone. This metabolite has been used for prenatal diagnosis from amniotic fluid samples. One case with a normal level of succinylacetone in amniotic fluid has recently been described (Grenier et al., 1996). Here, we report that this patient is a compound heterozygote for two known mutations: E364X and IVS6-1g-->t. The low level of succinylacetone cannot be explained by these mutations.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/genética , Líquido Amniótico/química , Genótipo , Heptanoatos/análise , Diagnóstico Pré-Natal , Tirosina/sangue , Erros Inatos do Metabolismo dos Aminoácidos/diagnóstico , Feminino , Heterozigoto , Humanos , Hidrolases/deficiência , Mutação , Linhagem , GravidezRESUMO
To study the expression of IL-13 receptor alpha1 (IL-13Ralpha1), specific monoclonal antibodies (mAb) were generated. Surface expression of the IL-13Ralpha1 on B cells, monocytes and T cells was assessed by flow cytometry using these specific mAb. Among tonsillar B cells, the expression was the highest on the IgD+ CD38- B cell subpopulation which is believed to represent naive B cells. Expression was also detectable on a large fraction of the IgD-CD38- B cells but not on CD38+ B cells. Activation under conditions which promote B cell Ig class switching up-regulated the expression of the receptor. However, the same stimuli had an opposite effect for IL-13Ralpha1 expression levels on monocytes. While IL-13Ralpha1 mRNA was clearly detectable in T cell preparations, no surface expression was detected. However, permeabilization of the T cells showed a clear intracellular expression of the receptor. A soluble form of the receptor was immunoprecipitated from the supernatant of activated peripheral T cells, suggesting that T cell IL-13Ralpha1 might have functions unrelated to the capacity to form a type II IL-4/IL-13R with IL-4Ralpha.
Assuntos
Linfócitos B/metabolismo , Interleucina-13/farmacologia , Interleucina-4/farmacologia , Monócitos/metabolismo , Receptores de Interleucina/metabolismo , Linfócitos T/metabolismo , Animais , Linfócitos B/imunologia , Linhagem Celular , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Interleucina-13/imunologia , Interleucina-13/metabolismo , Subunidade alfa1 de Receptor de Interleucina-13 , Interleucina-4/imunologia , Interleucina-4/metabolismo , Monócitos/imunologia , Receptores de Interleucina/imunologia , Receptores de Interleucina-13 , Linfócitos T/imunologiaRESUMO
The role of CD40 in the development of germinal centers (GC) is not simply to initiate the B cell response, as rudimentary GC can develop in CD40-/- mice that are injected with CD40-immunoglobulin (Ig) fusion protein. This indicates that CD40 ligand (CD40L) transduces a signal to T cells that is important in the process. In this study we have used an in vitro model of GC development to investigate the role of CD40L, cytokines and other co-stimuli. The model involves the specific induction of an H-2E transgene in GC B cells (in Sma58 mice). We find that Th2 cytokines together with Ig and CD40 cross-linking are the most efficient means of induction of the GC phenotype. Although IL-4 plays some inductive role, it is not the sole active ingredient in the mix of cytokines made by Th2 cells. Our studies on primary T cells and T cell clones activated in the absence of CD40 on antigen-presenting cells or CD40L on T cells indicate that the CD40L co-stimulus does not directly bias the response to Th2 cells, as previously reported, but that it augments terminal effector T cell differentiation or the level of secretory activity. However, both in vitro and in vivo, the CD40L co-stimulus is crucially important for Th2 development as in its absence IL-4 production is suboptimal and does not compete with a larger, more rapid IFN-gamma response.
Assuntos
Centro Germinativo/fisiologia , Interferon gama/biossíntese , Interleucina-4/biossíntese , Glicoproteínas de Membrana/fisiologia , Transdução de Sinais , Células Th2/fisiologia , Animais , Linfócitos B/fisiologia , Ligante de CD40 , Reagentes de Ligações Cruzadas , Imunofenotipagem , Interleucina-4/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Modelos Imunológicos , Células Th1/fisiologia , Células Th2/citologia , Células Th2/metabolismoRESUMO
Hereditary tyrosinemia type I (HTI, McKusick 276700) is an autosomal recessive disease caused by deficient fumarylacetoacetate hydrolase (FAH, EC 3.7.1.2) activity. HTI is characterized by progressive liver dysfunction with nodular cirrhosis often leading to hepatocellular carcinoma. Two extremes of the clinical phenotype have been described: the "acute" (severe, early onset and death) and "chronic" (delayed onset and slow course) phenotype. Allelic heterogeneity and/or mutation reversion in hepatic cells have been proposed earlier to explain the clinical heterogeneity. Two probands (one "acute," one "chronic") from the French-Canadian isolate where HTI is prevalent were studied. Both were homozygous (germ line) for the severe splice mutation IVS12 + 5g --> a; both showed liver mosaicism for FAH immunoreactivity with evidence for mutation reversion to heterozygosity (IVS12 + 5g --> a/+) in FAH-stained nodules as shown by amplification of DNA extracted from microdissected nodules. Western blot analysis of proteins from a reverted FAH-expressing nodule showed 29 +/- 3% FAH immunoreactive material as compared to an average normal liver. This was consistent with the measured FAA hydrolytic activity (25%) in this large regenerating nodule. These findings show that genotypic heterogeneity is not a sufficient explanation for clinical heterogeneity and implicate epigenetic and other factors modifying the phenotype in HTI.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/genética , Tirosina/sangue , Doença Aguda , Adolescente , Erros Inatos do Metabolismo dos Aminoácidos/enzimologia , Criança , Pré-Escolar , Doença Crônica , Feminino , Doenças Genéticas Inatas/enzimologia , Doenças Genéticas Inatas/genética , Genótipo , Heterozigoto , Homozigoto , Humanos , Hidrolases/deficiência , Hidrolases/genética , Hidrolases/metabolismo , Lactente , Recém-Nascido , Fígado/enzimologia , Fígado/metabolismo , Mutação/genética , LinhagemRESUMO
CD40 and CD40 ligand (CD40L) form one of most important receptor-ligand pairs that dock during T-B cell interactions as part of T-dependent antibody responses. It has been reported that among other cell types, B cells can express CD40L. Here we show that a large proportion of mouse B cells express CD40L in their cytoplasm, but not on the surface and that this is readily released as a soluble molecule. Thus, in their resting state up to 50% of mouse B cells express CD40L within their cytoplasm and both the proportion of cells expressing and the amount of CD40L is increased by signaling through immunoglobulin (Ig) or CD38. In contrast, T cell-derived signals such as CD40L (anti-CD40) or Th2-type cytokines cause a decrease in CD40L expression that is related to a release of a soluble form of the molecule from the cell. Supernatants from B cells activated with anti-Ig and anti-CD40 contain CD40L in a variety of forms (18 kDa, 33 kDa and 66 kDa) that are readily detectable by immunoprecipitation with CD40-Fc gamma fusion protein (CD40-Ig) followed by Western blotting with anti-CD40L antibody (MR1). The 33-kDa species is distinct from the 39-kDa membrane-bound molecule found in activated T cells or in resting B cells and appears to be a novel soluble form of CD40L. Inhibition of T cell-independent in vitro stimulation of B cells with CD40-Ig or anti-CD40L suggests that the B cell-derived soluble CD40L or CD40L expressed on the B cell surface can play a positive role in B cell proliferation.
Assuntos
Linfócitos B/metabolismo , Antígenos CD40/metabolismo , Citoplasma/metabolismo , Glicoproteínas de Membrana/metabolismo , Animais , Anticorpos Bloqueadores/farmacologia , Anticorpos Monoclonais/farmacologia , Linfócitos B/imunologia , Antígenos CD40/imunologia , Ligante de CD40 , Membrana Celular/imunologia , Membrana Celular/metabolismo , Células Cultivadas , Citoplasma/imunologia , Feminino , Líquido Intracelular/imunologia , Líquido Intracelular/metabolismo , Cinética , Ligantes , Ativação Linfocitária/imunologia , Glicoproteínas de Membrana/biossíntese , Glicoproteínas de Membrana/imunologia , Camundongos , Camundongos Endogâmicos DBA , Proteínas Recombinantes de Fusão/imunologia , Proteínas Recombinantes de Fusão/farmacologia , SolubilidadeRESUMO
We dissect in this article the roles of CD40 and its ligand in memory B-cell formation. Our data indicate that CD40 ligation does not directly lead to GC formation but it plays an indirect role related to maturation of helper T cells; signalling is bidirectional, to B cells, via CD40, upregulating cytokine receptor expression and to T cells, via CD40L, causing secretion of cytokines necessary for GC initiation. Later in the GC, CD40 selects mutated B cells for entry into the memory pool. This second T-cell-mediated CD40 ligation has consequences distinct from the first (rescue versus proliferation) that arise from rewiring of CD40 signal transduction pathways.
Assuntos
Linfócitos B/citologia , Linfócitos B/imunologia , Memória Imunológica , Animais , Antígenos CD40/metabolismo , Ligante de CD40 , Diferenciação Celular , Centro Germinativo/citologia , Centro Germinativo/imunologia , Humanos , Glicoproteínas de Membrana/metabolismo , Plasmócitos/citologia , Plasmócitos/imunologia , Transdução de Sinais/imunologia , Linfócitos T Auxiliares-Indutores/citologia , Linfócitos T Auxiliares-Indutores/imunologiaAssuntos
Linfócitos B/imunologia , Comunicação Celular/imunologia , Memória Imunológica , Linfócitos T/imunologia , Animais , Formação de Anticorpos , Antígenos CD40/fisiologia , Sobrevivência Celular/imunologia , Centro Germinativo/imunologia , Humanos , Switching de Imunoglobulina , Imunoglobulina G/biossíntese , Imunoglobulina M/biossíntese , Ativação Linfocitária , Camundongos , Camundongos Knockout , Linfócitos T Auxiliares-Indutores/imunologiaRESUMO
Hereditary tyrosinemia type I (HT I, McKusick 276,700) is a metabolic disease with a pattern of autosomal recessive inheritance. The disease is caused by a deficiency of the enzyme involved in the last step in the degradation of the amino acid tyrosine, fumarylacetoacetate hydrolase (FAH). The result of this block is the accumulation of catabolites some of which have been proposed to be highly toxic due to their alkylating potential. In humans, hereditary tyrosinemia is often associated with the development of hepatocellular carcinoma in young patients. The reasons for the high incidence of hepatocellular carcinoma are unknown but it has been suggested that it may be caused by accumulated metabolites such as fumarylacetoacetate (FAA) and maleylacetoacetate (MAA). The various mutational defects in the FAH gene are reviewed. The use of two mouse models of this disease to study the molecular basis of the pathologies associated with HT I are discussed. Finally, some preliminary data on the mutagenic potential of FAA and MAA in a gene reversal assay are presented.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/enzimologia , Hidrolases/deficiência , Tirosina/metabolismo , Erros Inatos do Metabolismo dos Aminoácidos/genética , Erros Inatos do Metabolismo dos Aminoácidos/fisiopatologia , Animais , Carcinoma Hepatocelular/epidemiologia , Carcinoma Hepatocelular/etiologia , Genes Recessivos , Humanos , Hidrolases/genética , Hidrolases/metabolismo , Incidência , Neoplasias Hepáticas/epidemiologia , Neoplasias Hepáticas/etiologia , Camundongos , Camundongos MutantesRESUMO
Hereditary tyrosinaemia type I (HTI), an autosomal recessive inborn error of metabolism, is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. The highest incidence of HTI is observed in the Saguenay-Lac-St-Jean region (SLSJ) (Québec, Canada), where 1 out of 22 individuals is thought to be a carrier. A splice mutation (IVS12 + 5G-->A) has recently been identified in this particular region. Here, we have determined the frequency of this mutation in a population of obligate carriers from the SLSJ region by allele-specific oligonucleotide hybridization and a method using a restriction enzyme digestion. Over 95 per cent of the HTI carriers were found to have the IVS12 + 5G-->A splice mutation. Screening for this mutation based on the two methods reported here is thus a reliable and rapid way of detecting carriers of hereditary tyrosinaemia type I in that region at high risk.